For a patient receiving 163 g of carbohydrate over 24 hours via tube feeding and using a 1‑unit‑per‑5‑gram carbohydrate‑to‑insulin ratio, what is the appropriate NPH (intermediate‑acting) insulin dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dosing for Tube Feeding with 163 g Carbohydrate Over 24 Hours

For a patient receiving 163 g of carbohydrate via tube feeding over 24 hours using a 1:5 carbohydrate‑to‑insulin ratio, the total daily NPH dose is approximately 33 units, divided as 16–17 units every 12 hours.

Dose Calculation

  • The American Diabetes Association recommends 1 unit of insulin for every 10–15 g of carbohydrate delivered by continuous or cycled tube feeding 1, 2.
  • Using the patient's specified 1:5 ratio (1 unit per 5 g carbohydrate), the calculation is: 163 g ÷ 5 = 32.6 units total daily dose 2, 3.
  • Round to 33 units per day for practical administration 1, 2.

NPH Administration Schedule

  • Administer NPH insulin twice daily (every 12 hours) to provide optimal basal coverage for continuous tube feeding 1, 2.
  • Split the total dose: 16–17 units every 12 hours (e.g., 16 U at 8 AM and 17 U at 8 PM, or 17 U twice daily) 1, 2.
  • NPH peaks 4–6 hours after administration, making twice‑daily dosing ideal for matching the continuous carbohydrate delivery 1, 4, 5.

Correction Insulin Protocol

  • Add regular human insulin every 6 hours (or rapid‑acting insulin every 4 hours) as correction doses in addition to scheduled NPH 1, 2.
  • Glucose >250 mg/dL: give 2 U regular insulin 1, 2.
  • Glucose >350 mg/dL: give 4 U regular insulin 1, 2.
  • Correction insulin must supplement—not replace—scheduled NPH; sliding‑scale monotherapy is condemned by major diabetes guidelines 1, 2.

Monitoring and Titration

  • Check glucose every 4–6 hours during tube feeding 1, 2.
  • Reassess the total NPH dose every 3 days based on average glucose trends 1, 2.
  • Average glucose ≥180 mg/dL: increase total daily NPH by 4 U every 3 days 1, 2.
  • Average glucose 140–179 mg/dL: increase total daily NPH by 2 U every 3 days 1, 2.
  • Target glucose range: 140–180 mg/dL for non‑critically ill hospitalized patients 1, 2.

Critical Safety Considerations

  • If tube feeding is interrupted, start a 10% dextrose infusion at 50 mL/h immediately to prevent severe hypoglycemia, because NPH insulin activity persists for 12–18 hours 1, 2.
  • For patients with type 1 diabetes, continue basal insulin even when feedings stop to prevent diabetic ketoacidosis 1, 2.
  • If any glucose reading falls <70 mg/dL, treat with 15 g fast‑acting carbohydrate (if feasible) and reduce the implicated NPH dose by 10–20% immediately 1, 2.

Common Pitfalls to Avoid

  • Do not use the standard 1:10–15 ratio when the patient's established ratio is 1:5; this would result in severe under‑dosing (only 11–16 U/day instead of 33 U/day) 1, 2, 3.
  • Avoid using sliding‑scale insulin as monotherapy; only ~38% achieve control versus ~68% with scheduled basal insulin 1, 2.
  • Do not delay insulin adjustments; 75% of hospitalized patients who develop hypoglycemia had no dose change before the next administration 1, 2.
  • Never discontinue NPH when tube feeding stops; switch to dextrose infusion instead to prevent hypoglycemia 1, 2.

Alternative Insulin Regimens (If NPH Unavailable)

  • Regular insulin every 6 hours: Total 33 U ÷ 4 doses = 8–9 U every 6 hours 1, 2.
  • Long‑acting basal insulin (glargine/detemir): Administer 50% of total dose (≈16 U) once daily plus correction insulin 1, 2.
  • However, NPH every 12 hours remains the preferred regimen for continuous tube feeding because its pharmacokinetic profile better matches the continuous carbohydrate delivery 1, 2, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

NPH Insulin Dosing for Cycled Tube Feeding in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Insulin glargine versus NPH insulin in patients with type 1 diabetes.

Drugs of today (Barcelona, Spain : 1998), 2003

Research

Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.

The Journal of clinical endocrinology and metabolism, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.